RxDoctor Payments Data

George Shanno, MD

Neurological Surgery · Vancouver, WANPI 1295780278

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,736 of the $8,170 with a category attached, or 70.2%. It is spread thinly across 28 manufacturers, the largest accounting for just 21.6%.

$8,170in general payments, 2019–2025

Across 126 payments — averaging $64.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$2K
  • Providence Medical Technology, Inc.$1K
  • Microvention, Inc.$1K
  • Globus Medical$997
  • Johnson & Johnson$542
  • Seaspine Orthopedics Corporation$417
  • plus $2K from 22 others

What the payments were for

  • Royalty or licence$87511%
  • Travel & lodging$1,46018%
  • Food & beverage$5,73670%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,170 in reported general payments places this provider in the 70th percentile of 175 neurological surgery providers in Washington.

See all neurological surgery providers in Washington

Medicare billing

Part B allowed, 2024
$187,959
Medicare patients
210
Services billed
1,784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone24$156
Gabapentin22$152
Cyclobenzaprine Hcl42$149
Ibuprofen35$146
Meloxicam30$104
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$93

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Vancouver

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →